Precision cancer testing personalized to cancer biology and the treatment journey.
We're not just advancing science - we're turning molecular data into treatment decisions that change outcomes.
At Datar Cancer Genetics, every test we build, every result we deliver, and every report we send exists for one reason - to provide the clearest possible picture of every cancer, so nothing is left to guesswork.
Trusted by oncologists across 50+ countries.
India's only US FDA-cleared comprehensive genomic profiling assay provider
· CAP-Accredited · CLIA Certified
[Find the Right Test for You Talk to Our Team →
What sets us apart?
For us, it's always personal. Precision diagnostics built around the individual — their cancer, their biology, their treatment journey — because no two cancers are the same, and neither are the patients who face them.
We deliver precise, customized cancer testing across the entire continuum of care through comprehensive tissue profiling and advanced liquid biopsies. Our technologies analyze molecular biomarkers to decode complex tumor biology at every critical milestone-from early detection and initial diagnosis to treatment selection, recurrence monitoring, and late-stage disease management. By providing both tissue-based insights and non-invasive liquid biopsy profiling, we enable truly personalized, targeted therapies tailored to the evolving reality of each patient's tumor.
If you have any questions or want to learn more, please contact us or visit our FAQs.
When treatment decisions matter most, molecular precision makes the difference.
Explore Multi-Omic Profiling
Keep a close watch on your progress and catch any changes early with regular monitoring
Explore Cancer Monitoring Solutions
Patients inspire everything we do. By connecting with them and their caregivers, we understand the challenges they face at every stage. Their stories help us address unmet needs in impactful ways, and by sharing these experiences, we inspire and support others on their journey.
Talk to Our Team
The Datar Cancer Genetics clinical laboratories in Nashik, India and Guildford, UK, are fully certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). Equipped with cutting-edge technology and advanced analytics, the UK lab is also registered with the Care Quality Commission (CQC) and holds UKAS accreditation (Medical Laboratory No. 22238), ensuring the highest standards in medical testing and diagnostics.
Cancer Screening
EasyCheck360 Intelli A Simple Blood Test for Cancer Screening in People Without SymptomsCancer Diagnosis
Trublood A Revolutionary Blood Test for Tumor Detection in Suspected CasesPersonalized Cancer Solutions
Exacta A Comprehensive Tumor Analysis for Personalized Treatment RecommendationsComprehensive Genomic Profiling(FDA Cleared)
CellDx-Tissue A Comprehensive Genomic Test to Identify Therapy Options for Advanced CancerMulti-Omics Tumour Profiling
Proxceq An Advanced Multi-Analyte Test Integrating Molecular and Functional Insights for Personalised Cancer Therapy GuidanceIn-vitro Chemosensitivity Resistance Profiling
Chemoscale Non-invasive Analysis for Choosing the Right Chemotherapy for Advanced CancerComprehensive Liquid Biopsy Profiling
Cancertrack A Simple Blood Test for Real-Time Tracking of Cancer Activity